首页> 美国卫生研究院文献>Canadian Journal of Kidney Health and Disease >Oral salt and water versus intravenous saline for the prevention of acute kidney injury following contrast-enhanced computed tomography: study protocol for a pilot randomized trial
【2h】

Oral salt and water versus intravenous saline for the prevention of acute kidney injury following contrast-enhanced computed tomography: study protocol for a pilot randomized trial

机译:口服盐水和水与静脉注射生理盐水预防对比增强的计算机断层扫描术后急性肾损伤:一项随机试验的研究方案

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundAlthough intravenous saline is the accepted prophylactic measure for the prevention of contrast- induced acute kidney injury, the oral route could offer an equivalent, practical, and cost saving approach. A systematic review of randomized trials that compared oral versus intravenous volume expansion for the prevention of radiocontrast-induced nephropathy in patients receiving arterial contrast reported no significant difference in the risk of contrast induced acute kidney injury between the oral and intravenous arms. Most trials for contrast nephropathy prevention have been in the setting of arterial contrast such as with cardiac catheterization, and not with venous contrast, such as computed tomography. The aim of this paper is to describe the protocol of a pilot trial comparing the effect of oral salt and water versus intravenous saline on the prevention of Acute Kidney Injury following contrast-enhanced computed tomography.
机译:背景技术尽管静脉注射生理盐水是预防对比剂诱发的急性肾损伤的公认预防措施,但口服途径可提供一种等效,实用且节省成本的方法。对接受动脉造影的患者进行口服对比静脉内扩容预防放射性造影剂肾病的随机试验的系统评价,发现口服和静脉内造影剂引起的急性肾损伤风险无显着差异。大多数预防造影剂肾病的试验都是在设置动脉造影剂的情况下,例如心脏导管检查,而不是在静脉造影剂的情况下,例如计算机断层扫描。本文的目的是描述一项对比造影剂计算机断层扫描后比较口服盐和水与静脉内盐水对预防急性肾脏损伤的效果的试验性试验方案。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号